BRIEF-Alumis, Acelyrin To Merge Creating A Late-Stage Clinical Biopharma Company
ReutersFeb 6, 2025 10:56 PM
Feb 6 (Reuters) - Alumis Inc ALMS.O:
ALUMIS AND ACELYRIN TO MERGE CREATING A LATE-STAGE CLINICAL BIOPHARMA COMPANY DEDICATED TO INNOVATING, DEVELOPING AND COMMERCIALIZING TRANSFORMATIVE THERAPIES FOR IMMUNE-MEDIATED DISEASES
Source text: ID:nGNX36S1bS
Further company coverage: ALMS.O
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Workday Q2 Revenue Jumps on AI Growth
Workday(NASDAQ:WDAY) reported its fiscal Q2 2026 results (period ended July 31, 2025) on Aug. 21, 2025, delivering 14% year-over-year subscription revenue growth to $2.17 billion with a non-GAAP operating margin of 29% and raised full-year fiscal 2026 guidance across key metrics.The Motley Fool
5 hours ago
Japan July CPI Preview: With Inflation Cooling, Will the Yen Still Rise?
TradingKey - Japan is set to release July inflation data on 22 August 2025. Market consensus predicts that the national Consumer Price Index (CPI) excluding fresh food will see its year-on-year increase slow from 3.3% in June to 3%. While forecasts for headline CPI and CPI excluding food and...TradingKey
Tue, Aug 19
Powell's Jackson Hole Speech: For U.S. Stocks, Hawk or Dove Signal Could Be a Lose-Lose?
TradingKey - As U.S. inflation and labor market data show signs of rebalancing, Treasury traders and Wall Street banks have largely priced in a rate cut at the September FOMC meeting — the first of 2025. Yet both a more dovish-than-expected tone and a potential surprise hawkish signal from Fed ChairTradingKey
Mon, Aug 18
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...TradingKey
Mon, Aug 18
[IN-DEPTH ANALYSIS] Observing Bitcoin Price Trends from a Macroeconomic Perspective
After a comprehensive analysis, we believe that three favourable factors will overshadow a single adverse factor, supporting a continued upward price trend for cryptocurrencies, with Bitcoin at the forefront.TradingKey
Mon, Jun 9
